AMPX three-lens brief
Evidence-based stock research on AMPX. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -3.24% yesterday. · Trading at 11% of its 52-week range — deep in the lower band.
- Moved -3.24% yesterday.
- Trading at 11% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Outperforming SPY by 9.3pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
AMPX closed at $9.55 (-3.24%) as of 2026-09-11. Market cap: $1.40B. Price is below the 50-day MA and below the 200-day MA. Positives: outperforming SPY by 9.3pp over 30 days.; analyst mean target $23.00 — 141% above current (9 analysts).. Concerns: moved -3.24% yesterday.; trading at 11% of its 52-week range — deep in the lower band.. Last quarter: Revenue $34.03M, net income -$5.08M, free cash flow -$35.90M.
Why three lenses on AMPX, not one.
A single reasoning model has blind spots it doesn’t know about. We examine AMPXacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/AMPX" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath AMPX brief"></iframe>